CD19/BCMA CAR-NK
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/BCMA CAR-NK, covering 2025-12-23 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease [EARLY_Phase 1]